Cytokeratin staining and other sentinel node controversies

Area of Science:

• Oncology
• Surgical Pathology
• Breast Cancer Research

Background:

• Sentinel lymph node (SLN) biopsy is a standard for breast cancer staging, offering higher sensitivity and lower morbidity than axillary dissection.
• The detection of micrometastases in SLNs has increased with advanced techniques, but their clinical relevance remains a subject of debate.

Purpose of the Study:

• To evaluate the clinical significance of micrometastases found in sentinel lymph nodes during breast cancer staging.
• To assess the utility of ultrasensitive detection methods and immunohistochemistry (IHC) in managing breast cancer nodal status.

Main Methods:

• Review of available data on the prognostic significance of axillary metastases based on size.
• Analysis of studies utilizing immunohistochemistry (IHC) for SLN analysis.
• Evaluation of lymphoscintigraphy findings for alternative nodal basin drainage patterns.

Main Results:

• Metastases smaller than 0.2 mm appear to have a similar prognosis to node-negative disease, questioning the utility of ultrasensitive tests.
• Immunohistochemistry (IHC) upstages 2%-20% of SLNs, leading to further axillary dissection in about 10% of cases.
• Lymphoscintigraphy identifies alternative drainage patterns, but this rarely impacts chemotherapy decisions.

Conclusions:

• The clinical relevance of micrometastases detected by ultrasensitive methods needs careful consideration to avoid overtreatment.
• Immunohistochemistry (IHC) may be valuable for staging, but its role in ductal carcinoma in situ requires further clinical trial evaluation.
• Internal mammary SLN biopsy shows potential for specific patient groups but needs more research.